Summary:
A PHASE 3 RANDOMIZED, DOUBLE-BLIND, MULTI-DOSE, PLACEBO AND NSAID-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FASINUMAB IN PATIENTS WITH PAIN DUE TO OSTEOARTHRITIS OF THE KNEE OR HIP.
Qualified Participants Must:
At least 18 years old
BMI less than 39
Clinical Diagnosis of Osteoarthritis on hip or knee
Moderate to severe pain on hip or knee
Currently on pain medication
Qualified Participants May Receive:
Free exams, free lab tests and free Xrays and MRI.